K-to-R Transition Program Session: Networking and Finding Research Collaborators
To register, click here. Questions? Contact Mia Terkowitz, [email protected]
Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis
ARTICLE: Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis AUTHORS: Jeffrey A Tornheim, Zarir F Udwadia, Prerna R Arora,… Read More »Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial
ARTICLE: A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial AUTHORS: Sunil S… Read More »A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial
Young Investigators’ Day Award Recipients
Young Investigators’ Day was established in 1978 to recognize young investigators who are trained at Johns Hopkins University School of Medicine and to provide them… Read More »Young Investigators’ Day Award Recipients
Faculty Promotions and Additions
Congratulations to the below faculty members who were recently promoted. Professor Bimal Ashar, GIM Peter Toth, adjunct professor, Cardiology (not pictured) Associate Professor Majd AlGhatrif,… Read More »Faculty Promotions and Additions
Epic Tips: April 15, 2022
Inpatient & Ambulatory: Navigating Results Review - 5 Key Points Screenshots of the below are available here. Select “All Rows” to stop rows from disappearing… Read More »Epic Tips: April 15, 2022
April is Sarcoidosis Awareness Month
Today, it is estimated that 175,000 people in the U.S. have sarcoidosis, with an estimated 1.2 million individuals living with the disease worldwide. Despite increasing… Read More »April is Sarcoidosis Awareness Month
Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Solid-organ Transplant Recipients on Continuous Veno-venous Hemodialysis
ARTICLE: Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Solid-organ Transplant Recipients on Continuous Veno-venous Hemodialysis AUTHORS: Andrew S Jarrell, Jessica R Crow, Sara E Strout, Rachel M Kruer, Lindsey P… Read More »Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Solid-organ Transplant Recipients on Continuous Veno-venous Hemodialysis
Complex decay dynamics of HIV virions, intact and defective proviruses, and 2LTR circles following initiation of antiretroviral therapy
ARTICLE: Complex decay dynamics of HIV virions, intact and defective proviruses, and 2LTR circles following initiation of antiretroviral therapy AUTHORS: Jennifer A White, Francesco R Simonetti, Subul… Read More »Complex decay dynamics of HIV virions, intact and defective proviruses, and 2LTR circles following initiation of antiretroviral therapy
Human Aging Project Scholars
The Johns Hopkins Human Aging Project (HAP) works to make research and program development funding available to faculty members through the HAP Scholars Program. HAP… Read More »Human Aging Project Scholars